NA-Semax Amidate
N-Acetyl Semax Amidate
NA-Semax Amidate (N-Acetyl Semax Amidate) is a synthetic, doubly-modified analog of the melanocortin-derived heptapeptide Semax, featuring both N-terminal acetylation and C-terminal amidation to significantly enhance metabolic stability and CNS penetration. It is primarily used as a nootropic and neuroprotective agent for cognitive enhancement, anxiety reduction, BDNF upregulation, and recovery from neurological stress or injury. Compared to base Semax, the amidate form is considered more potent on a per-microgram basis and longer-acting, making it the preferred variant among experienced users.
Mechanism of Action
NA-Semax Amidate modulates the melanocortin system via MC4R agonism and influences ACTH-related signaling pathways, though its primary nootropic effects are largely attributed to robust upregulation of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in the hippocampus and prefrontal cortex. It also modulates dopaminergic and serotonergic tone, enhances cerebral microcirculation, and reduces neuroinflammatory signaling via downregulation of pro-inflammatory cytokines such as IL-6 and TNF-alpha. The dual N-acetyl and C-amide modifications protect the peptide from rapid enzymatic degradation by aminopeptidases and carboxypeptidases, extending its effective half-life and bioavailability relative to unmodified Semax.
Evidence by Health Goal(5 goals)
Dosing Protocols
Morning, or morning and early afternoon to avoid disrupting sleep architecture
Cycle: 4-8 weeks on, 2-4 weeks off
Most common route of administration. Due to higher potency versus base Semax, start at 100mcg per dose. Each nostril receives half the total dose. Cycling is recommended to prevent receptor desensitization and maintain BDNF response magnitude.
Morning, preferably on an empty stomach or light meal
Cycle: 4-6 weeks on, 2-4 weeks off
Subcutaneous injection offers more precise dosing and bypasses nasal absorption variability. Lower doses are effective due to improved bioavailability. Use insulin syringes with bacteriostatic water for reconstitution. Less commonly used than nasal route for this compound.
Safety & Side Effects
NA-Semax Amidate has a favorable short-term safety profile based on preclinical data and extensive anecdotal use, with no reported serious adverse events at typical research doses; however, long-term human safety data are absent and no randomized clinical trials exist in healthy populations. It is an unscheduled research chemical in most Western jurisdictions but is not approved for human therapeutic use by the FDA or EMA, and quality control across peptide vendors varies significantly.
Possible Side Effects
- !Transient nasal irritation or mild burning sensation at site of intranasal administration
- !Headache, typically mild and resolving within 1-2 hours, especially at higher doses
- !Heightened irritability or emotional sensitivity in some users, particularly during initial use
- !Fatigue or sedation in a minority of users, possibly reflecting altered serotonergic tone
- !Insomnia or sleep disruption if dosed too late in the day
- !Mild appetite suppression via melanocortin system engagement
- !Temporary flushing or warmth sensations, consistent with ACTH-related peptide activity
Interactions
- -May potentiate the anxiolytic or sedative effects of GABAergic compounds (e.g., benzodiazepines, phenibut) — use with caution and reduce doses of both
- -Additive cognitive and BDNF-enhancing effects possible when combined with other nootropic peptides such as Selank or BPC-157 — monitor for overstimulation
- -May modulate dopamine receptor sensitivity — caution with dopaminergic medications (e.g., stimulants, antipsychotics, l-DOPA) due to unpredictable interaction potential
- -Theoretical synergy with antidepressants affecting BDNF (e.g., SSRIs, SNRIs) — not recommended to combine without medical supervision due to serotonergic overlap
- -May influence cortisol dynamics via ACTH-pathway modulation — caution in individuals on corticosteroids or with HPA axis disorders
Cost & Where to Buy
Cost depends heavily on concentration (typically sold as 30mg/mL nasal spray vials), vendor reputation, and quantity purchased. A standard 15mL nasal spray vial at 30mg/mL provides approximately 450mg total peptide, which at 200mcg/day covers several months, making per-dose cost relatively low. Higher costs reflect pharmaceutical-grade purity testing (HPLC, mass spec verification). Peptide degradation from improper storage can reduce effective value.
Search on Amazon